Can We Stop Mass Drug Administration Prior to 3 Annual Rounds in Communities With Low Prevalence of Trachoma? PRET Ziada Trial Results

Interview with C. Jason Wang, MD, PhD, author of Improving Preterm Ophtalmologic Care in the Era of Accountable Care Organizations.

9 Heinä 201212min

Interview with Jonathan H. Lass, MD, author of Relationship of Fuchs Endothelial Corneal Dystrophy Severity to Central Corneal Thickness

9 Huhti 20126min

Interview with Samuel G. Jacobson, MD, PhD, author of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years

9 Tammi 20127min

Interview with Patricia Chévez-Barrios, MD, author of Outcomes of Integrating Genetics in Management of Patients With Retinoblastoma

14 Marras 201110min